CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer

Clinical Trial ID NCT01218867

Rank	Title	Journal	Year	PubWeight™‹?›
1	Adoptive immunotherapy for cancer: building on success.	Nat Rev Immunol	2006	7.76
2	Progress in human tumour immunology and immunotherapy.	Nature	2001	6.97
3	T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.	J Exp Med	1980	3.17
4	CAR T cells for solid tumors: armed and ready to go?	Cancer J	2014	1.29
5	Trial Watch: Adoptive cell transfer immunotherapy.	Oncoimmunology	2012	1.18
6	Driving CAR T-cells forward.	Nat Rev Clin Oncol	2016	1.09
7	Immunotherapy targets in pediatric cancer.	Front Oncol	2012	0.97
8	Immunotherapy for ovarian cancer.	Curr Treat Options Oncol	2015	0.89
9	Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma.	J Clin Cell Immunol	2015	0.84
10	Immune checkpoints and immunotherapy for colorectal cancer.	Gastroenterol Rep (Oxf)	2015	0.83
11	Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.	Eur J Cardiothorac Surg	2015	0.77
12	Update on use of aldesleukin for treatment of high-risk metastatic melanoma.	Immunotargets Ther	2015	0.76